QA: Oncternal Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001260990_2019_Oncternal_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001260990, Oncternal Therapeutics Inc

  xvar xval
0 AssetsCurrent 31,208,000
1 IntangibleAssetsNetIncludingGoodwill 94,000
2 PropertyPlantAndEquipmentNet 19,000
3 remainder_Assets 0
4 LiabilitiesCurrent 5,210,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,346,899
9 ResearchAndDevelopmentExpense 32,702,220
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 514,892
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 31,321,000
1 Liabilities 5,210,000
2 Expenses 42,049,119
3 Revenues 0
4 StockholdersEquity 26,111,000
5 NetIncome -41,534,227
6 ComprehensiveNetIncome -41,534,227
7 BaseVar 39,547,506
8 EconomicCapitalRatiobeforeLimitedLiability 0.842
9 EconomicCapitalRatio 2.18

Edgar->Model Mapping

Feature Distribution

Change over Time